Detalhe da pesquisa
1.
Ustekinumab in Crohn's disease: real-world outcomes and predictors of response.
Rev Esp Enferm Dig
; 114(5): 272-279, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393332
2.
Intravenous ustekinumab reinduction as a Crohn's disease rescue strategy following a secondary non-response.
Rev Esp Enferm Dig
; 111(9): 721, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31333034
3.
The onset of ulcerative colitis during treatment with secukinumab: can anti-IL-17A be a trigger for inflammatory bowel disease?
Rev Esp Enferm Dig
; 111(9): 720-721, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31333036
4.
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months.
Rev Esp Enferm Dig
; 110(9): 564-570, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29893581
5.
Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin.
Rev Esp Enferm Dig
; 109(2): 130-136, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28071062
6.
Initial experience with golimumab in clinical practice for ulcerative colitis.
Rev Esp Enferm Dig
; 108(3): 129-32, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26786341
7.
Prevalence of Primary Resistance of Helicobacter pylori to Clarithromycin and Levofloxacin in Southern Spain.
Digestion
; 92(2): 78-82, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26227669
8.
Crohn's-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab.
Rev Esp Enferm Dig
; 105(5): 299-302, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23971663
9.
Ustekinumab en la enfermedad de Crohn: resultados en la vida real y posibles factores de respuesta / Ustekinumab in Crohn's disease: real-world outcomes and predictors of response
Rev. esp. enferm. dig
; 114(5): 272-279, mayo 2022. tab, graf
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-205627
10.
Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal.
Inflamm Bowel Dis
; 21(7): 1564-71, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26070002
11.
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months
Rev. esp. enferm. dig
; 110(9): 564-570, sept. 2018. tab, graf
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-177777
12.
[Extraintestinal manifestations in Whipple's disease]. / Manifestaciones extraintestinales en la enfermedad de Whipple.
Gastroenterol Hepatol
; 30(6): 371-2, 2007.
Artigo
em Espanhol
| MEDLINE | ID: mdl-17662223
13.
Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohns disease with fecal calprotectin
Rev. esp. enferm. dig
; 109(2): 130-136, feb. 2017. tab, ilus
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-159856
14.
Initial experience with golimumab in clinical practice for ulcerative colitis
Rev. esp. enferm. dig
; 108(3): 129-132, mar. 2016. tab, graf
Artigo
em Inglês
| IBECS (Espanha) | ID: ibc-148605
15.
Debut de colitis ulcerosa en contexto de tratamiento con secukinumab: ¿los anti-IL-17A pueden ser un factor desencadenante para la aparición de la enfermedad inflamatoria intestinal? / The onset of ulcerative colitis during treatment with secukinumab: can anti-IL-17A be a trigger for inflammatory bowel disease?
Rev. esp. enferm. dig
; 111(9): 720-721, sept. 2019. tab
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-190360
16.
Reinducción intravenosa de ustekinumab tras pérdida de respuesta secundaria como estrategia de rescate en la enfermedad de Crohn / Intravenous ustekinumab reinduction as a Crohn's disease rescue strategy following a secondary non-response
Rev. esp. enferm. dig
; 111(9): 721-721, sept. 2019.
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-190361
17.
Enfermedad de Crohn-like en un paciente con inmunodeficiencia común variable tratada con azatioprina y adalimumab / Crohns-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab
Rev. esp. enferm. dig
; 105(5): 299-302, mayo -jun. 2013. ilus
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-115741